NCT00005056View on ClinicalTrials.gov

Bryostatin 1 In Treating Patients With Progressive Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 1999

Study Completion Date

July 31, 2006

Conditions
Kidney Cancer
Interventions
DRUG

bryostatin 1

Trial Locations (2)

0X3 7LJ

Oxford Radcliffe Hospital, Oxford

OX3 7LJ

Imperial Cancer Research Fund Medical Oncology Unit, Oxford

Sponsors

Lead Sponsor

Cancer Research UK
All Listed Sponsors
lead

Cancer Research UK

OTHER

NCT00005056 - Bryostatin 1 In Treating Patients With Progressive Kidney Cancer | Biotech Hunter | Biotech Hunter